Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NCNA announces 1:25 reverse split.
https://finance.yahoo.com/news/nucana-announces-plan-implement-ads-203000210.html
NCNA has until 5/6/2024 to attain NASDAQ's minimum bid requirement of $1.00.
So though not inevitable, I'd agree that the possibility of an RS is highly likely.
Another possibility is for NCNA to partner with a large pharma company to begin one or more clinical trials with one or more of their patented drugs. If they haven't had any conversations about this up to now, I'd say it's highly unlikely any partnership agreement could be finalized in the ~1 month remaining before they will be subject to delisting by NASDAQ.
Needless to say, I'm very glad I was able to sell all my NCNA shares during the recent runup. And I likely won't be buying any shares up to May 6. If NCNA does decide to do a reverse split to remain quoted on NASDAQ, I will reconsider my stance.
I think a reverse split is inevitable
Still on radar but not buying any yet.
Looking for something closer to $.30 or perhaps slightly lower ($.28-.29)
Not in a rush to buy back. Still a chance they get delisted or perhaps execute a reverse split to raise their bid price above $1. A lot of uncertainty in this ticker as far as I'm concerned. Was happy to sell my shares around $.80. Didn't have that many shares but was a nice profit anyway.
Wow. We might see .20’s
Gap looking filled :) I just wonder who’s buying.
In the .40’s. Looks like a good place to grab a little more. Can’t imagine it going into .30’s
NCNA: Great DD, too!!! Boy, I got SUCKERED!! (But, I'll only cry just a few more hours --- see me, live, below!!)
"Yeah, sure!!! And I myself just got a Patent to kill CANCER too!!! I grow the Cancer cells in a Petri Dish, then toss ARCO-PREMIUM-TOP-TIER-GASOLINE on it, and hit it with my Bic CIGARETTE LIGHTER!!! Works every time!!!"
Just did a patent search for NCNA and found ~17 patents they have received using PHOSPHORAMIDATE derivatives.
One dates back to 2016! -lol
https://patents.justia.com/assignee/nucana-plc
NCNA: CONGRATS, Dude!!! You worked it as a PRO would!!! (I worked it like a FOOL!!! Dumped all awhile back, at a LOSS!! Good thing I did NOT 'toss-the-farm' at it!!) And indeed, just like you too emphasized, any OTHER firm would have HYPED-the-fluck out of any kind of Cancer-related Patent, but this firm did NOTHING.)
CONGRATS again!!!
Was "lucky" and got up early this morning.
I was able to sell all my shares pre-market at around $.81 >
You're right to worry about the "stealth" patent though. Most companies would brag about even having an application in process in the US.
Wonder why they have been so secretive about this patent?
NCNA: Most worrisome here --- via my own stupid, belated hindsight --- was that there was NO Company PR, nor otherwise "NEWS", about their own new PATENT. THAT is really, really, really, WORRISOME!!!!
Getting and staying over $1 is a big deal now.
If NCNA can do that they will not be in danger of delisting from NASDAQ. Otherwise delisting or a reverse split might be on the table. They have until May 6, 2024 to meet NASDAQ minimum bid price listing requirement.
https://ir.nucana.com/news-releases/news-release-details/nucana-announces-listing-transfer-nasdaq-capital-market
Same. I have a starter. Will avg down if it hits where I want.
Like I said, NCNA future all depends on what they can do with the patent.
If they are smart they already had "somethings" lined up before the approval. Now that approval has been achieved may take some time to finalize a deal with someone in big pharma. May go back into the 40's if the wait becomes more than a week or 2. But that is just my own guess.
Keeping on my radar for now.
Yeah. It may not happen. It has traded the float above the .50 area. Hit $1 in PM, so maybe it comes again
Low so far today is $.571 >
$.40's seems a stretch at least for today. But if it gets that low will rebuy shares.
Future for this ticker depends on what they do with their brand new US Patent. Sell it outright or use it as "bait" for a partnership with big Pharma? (imo)
I wouldn’t mind seeing it in the .40’s before running though.
NCNA: This may run now, since the FLUFF "news" baloney is OVER at the scam PR of the day, namely, @GXAI.
Let’s see if .40 gap closes.
Let’s see if they can get over $1 and hold
Strong patent news but over extended seems like, slow day in the market tho and holding so let’s see
NCNA: I think this puppy is on the TOP of this list for SOME reason ---
https://www.benzinga.com/premarket
NCNA: News about Patent for Cancer treatment.
https://beststocks.com/title-nucana-receives-us-patent-for-phosphora/
NCNA: Here's today's (reclusive) NCNA Firm's Patent news item:
https://www.benzinga.com/wiim/24/03/37635513/nucana-shares-are-trading-higher-after-the-company-was-granted-u-s-patent-11925658-for-phosphoramida
"NuCana shares are trading higher after the company was granted U.S. Patent #11925658 for Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance"
NCNA: Unfortunately for ME, that's 1:00 a.m.!!! (I HATE San Diego!! By the Open, I get sloppy 3rd's, 4th's, or 5th's. I need WeBull, plus a stay-awake or 'Dracula-Drug'.)
NCNA: Cancer + England + Lots of Trials --- well, just may be a monster WINNING formula for Wednesday.
Move yesterday was probably due to anticipated presentations at a Cancer Therapeutics 2023 conference.
https://finance.yahoo.com/news/nucana-announces-presentations-aacr-nci-120000333.html
I think we see $4 soon enough. By the end of this week or next. IMO. $NCNA
Agreed. GL
$NCNA
This one is a no brainer.
Loaded heavy end of day. Looking forward to tomorrow here. $NCNA
Undervalued even after the massive gains this month. Do not underestimate the recent patent infringement ruling out of Germany. More to come. Stand by...
Just my conjecture but the recent news gave it momentum, for sure!
Nah....that's not the reason...just look up the company...you'll see why. Its recent news
Increasing volume and upward trend over the past 3 to 4 days could be indicative that the market may be sensing more FDA news or announcement in the short term. A good stock to hold IMHO.
NuCana Receives FDA Fast Track Designation For Acelarin (NUC-1031) For Treatment Of Biliary Tract Cancer.
Followers
|
6
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
56
|
Created
|
01/29/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |